Historic CAR-T Cell Trial Begins in Brazil

Brazil’s health officials have okayed a first-of-its-kind CAR-T Cell therapy trial. Anvisa, the health agency, announced the decision. Conducted by FUNDHERP and the Butantan Institute, the study will involve 81 patients. The trial is in its starting phase. It aims to evaluate the treatment’s safety and effectiveness. Specifically, it targets patients with certain types of […]

Leave a Reply

Your email address will not be published. Required fields are marked *